Alogliptin
5 NDCs across 2 manufacturers|3 Generic,2 Brand
Alogliptin is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
Alogliptin is available as 5 NDCs from 2 manufacturers (3 generic, 2 brand), with NADAC prices from $4.92 to $13.14 per EA — the most expensive product costs about 2.7× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
5
3G / 2B
Manufacturers
2
competing in market
Price Spread
$4.92 – $13.14
per EA
7d Activity
avg +0.7% WoW · of 5 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
2 manufacturers producing ALOGLIPTIN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
NESINA 12.5 MG TABLET | $13.1377 per EA | — |
NESINA 25 MG TABLET | $13.0731 per EA | — |
ALOGLIPTIN 6.25 MG TABLET | $5.1804 per EA | +2.18% |
ALOGLIPTIN 12.5 MG TABLET | $5.0543 per EA | +0.09% |
ALOGLIPTIN 25 MG TABLET | $4.9231 per EA | -0.10% |
Frequently Asked Questions
What is Alogliptin used to treat?
Alogliptin is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
How many Alogliptin products are on the market?
The Alogliptin drug market contains 5 NDCs from 2 manufacturers — 3 generic and 2 brand products.
What is the price range for Alogliptin?
NADAC reference prices for Alogliptin range from $4.9231 to $13.1377 per EA — the most expensive product costs about 2.7× the cheapest.
Is generic Alogliptin cheaper than brand?
The average generic NADAC for Alogliptin is $5.0526 per EA, versus $13.1054 for brand-labeled products — brand versions average about 2.6× the generic price.
Which manufacturers make Alogliptin?
2 manufacturers list Alogliptin in NADAC. Ranked by number of NDCs, the largest are Padagis Israel Pharmaceuticals Ltd (3), Takeda Pharmaceuticals America, Inc. (2).
How has the price of Alogliptin changed recently?
Over the past 7 days, 2 Alogliptin NDCs rose and 1 fell, with a market-wide average change of +0.7%.